One Fat Can Prevent Dementia — If You Eat It Long-term

Physionic

Nov 26, 2025

Episode description

JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2 HEALTH AUTONOMY [COURSE]Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomyJOIN THE COMMUNITYJoin my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2EMAIL LIST1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6HIRE ME FOR CONSULTING: Consulting: https://bit.ly/3dmUl2H Created with BiorenderOmega-3 Clinical Trials: https://youtu.be/NScltXkIO44?si=DYhUHP8YWU897qhAOmega-3 Brain Mechanisms: https://youtu.be/7dwsjFAP5rQ?si=_5X0LEH3v7vBPsbB0:00 - Introduction0:48 - DHA and Dementia2:56 - Two Problems4:50 - Alzheimer's Risk6:52 - Long-term? How do I apply this?8:50 - Main Points / Key TakeawaysReference[Study 546] Wei BZ, Li L, Dong CW, Tan CC, Alzheimer’s Disease Neuroimaging Initiative, Xu W. The relationship of omega-3 fatty acids with dementia and cognitive decline: evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. Am J Clin Nutr. 2023;117(6):1096-1109. doi:10.1016/j.ajcnut.2023.04.001.Funding/Conflicts: Public funding: This study was supported by grants from the National Natural Science Foundation of China (grant 82001136) and the Tai-Shan Scholar Project; data collection and sharing for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) used in this work were funded by the National Institutes of Health (National Institute on Aging and National Institute of Biomedical Imaging and Bioengineering) and the U.S. Department of Defense (award W81XWH-12-2-0012); Non-profit funding: Additional support for ADNI came from organizations such as the Alzheimer’s Association and the Alzheimer’s Drug Discovery Foundation, with private-sector contributions coordinated through the Foundation for the National Institutes of Health;Industry funding: ADNI also received funding from numerous pharmaceutical, biotech, and imaging companies, including AbbVie, Araclón Biotech, BioClinica, Biogen, Bristol-Myers Squibb, CereSpir, Cogstate, Eisai, Elan Pharmaceuticals, Eli Lilly, EuroImmun, F. Hoffmann-La Roche/Genentech, Fujirebio, GE Healthcare, IXICO, Janssen Alzheimer Immunotherapy, Johnson & Johnson Pharmaceutical Research & Development, Lumosity, Lundbeck, Merck, Meso Scale Diagnostics, NeuroRx Research, Neurotrack Technologies, Novartis, Pfizer, Piramal Imaging, Servier, Takeda, and Transition Therapeutics; Conflicts of interest: The authors report no conflicts of interest.CRITIQUES, RULES, AND NOTESBe aware of the following rules before posting comments:- Please do not post summaries of the video in the comments - it damages retention on the video and YouTube is less likely to promote it (these videos cost me a lot of money to produce). Critiques of my work are welcome! Please be aware of the following notes & rules before submitting critique:Be mindful that this content is not all encompassing on the subject at hand and is self-limited for brevity to reach a wider audience. Also, be aware that I receive hundreds of YouTube comments per day, so the only way your critique can be considered is if you follow the steps outlined below. Finally, YouTube auto-deletes links, so I do not see most comments with links attached. RULES:If your comment is rude, you will be banned.If your comment is not about the studies/topics at hand (i.e. extending to other outcomes not discussed) or offers critique with no scientific basis, it is unlikely to receive a response.If you can follow these rules, I will try to address your critique and if there is merit, I will add an AMENDMENT to the content in question and pin it so everyone can see it (thank you!). Please use the following link to submit your critique: https://bit.ly/PhysionicCritiqueDisclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes. #omega3 #dementiaprevention #dementiatreatment

Episode description

JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2 HEALTH AUTONOMY [COURSE]Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomyJOIN THE COMMUNITYJoin my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2EMAIL LIST1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6HIRE ME FOR CONSULTING: Consulting: https://bit.ly/3dmUl2H Created with BiorenderOmega-3 Clinical Trials: https://youtu.be/NScltXkIO44?si=DYhUHP8YWU897qhAOmega-3 Brain Mechanisms: https://youtu.be/7dwsjFAP5rQ?si=_5X0LEH3v7vBPsbB0:00 - Introduction0:48 - DHA and Dementia2:56 - Two Problems4:50 - Alzheimer's Risk6:52 - Long-term? How do I apply this?8:50 - Main Points / Key TakeawaysReference[Study 546] Wei BZ, Li L, Dong CW, Tan CC, Alzheimer’s Disease Neuroimaging Initiative, Xu W. The relationship of omega-3 fatty acids with dementia and cognitive decline: evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. Am J Clin Nutr. 2023;117(6):1096-1109. doi:10.1016/j.ajcnut.2023.04.001.Funding/Conflicts: Public funding: This study was supported by grants from the National Natural Science Foundation of China (grant 82001136) and the Tai-Shan Scholar Project; data collection and sharing for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) used in this work were funded by the National Institutes of Health (National Institute on Aging and National Institute of Biomedical Imaging and Bioengineering) and the U.S. Department of Defense (award W81XWH-12-2-0012); Non-profit funding: Additional support for ADNI came from organizations such as the Alzheimer’s Association and the Alzheimer’s Drug Discovery Foundation, with private-sector contributions coordinated through the Foundation for the National Institutes of Health;Industry funding: ADNI also received funding from numerous pharmaceutical, biotech, and imaging companies, including AbbVie, Araclón Biotech, BioClinica, Biogen, Bristol-Myers Squibb, CereSpir, Cogstate, Eisai, Elan Pharmaceuticals, Eli Lilly, EuroImmun, F. Hoffmann-La Roche/Genentech, Fujirebio, GE Healthcare, IXICO, Janssen Alzheimer Immunotherapy, Johnson & Johnson Pharmaceutical Research & Development, Lumosity, Lundbeck, Merck, Meso Scale Diagnostics, NeuroRx Research, Neurotrack Technologies, Novartis, Pfizer, Piramal Imaging, Servier, Takeda, and Transition Therapeutics; Conflicts of interest: The authors report no conflicts of interest.CRITIQUES, RULES, AND NOTESBe aware of the following rules before posting comments:- Please do not post summaries of the video in the comments - it damages retention on the video and YouTube is less likely to promote it (these videos cost me a lot of money to produce). Critiques of my work are welcome! Please be aware of the following notes & rules before submitting critique:Be mindful that this content is not all encompassing on the subject at hand and is self-limited for brevity to reach a wider audience. Also, be aware that I receive hundreds of YouTube comments per day, so the only way your critique can be considered is if you follow the steps outlined below. Finally, YouTube auto-deletes links, so I do not see most comments with links attached. RULES:If your comment is rude, you will be banned.If your comment is not about the studies/topics at hand (i.e. extending to other outcomes not discussed) or offers critique with no scientific basis, it is unlikely to receive a response.If you can follow these rules, I will try to address your critique and if there is merit, I will add an AMENDMENT to the content in question and pin it so everyone can see it (thank you!). Please use the following link to submit your critique: https://bit.ly/PhysionicCritiqueDisclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes. #omega3 #dementiaprevention #dementiatreatment

Mindsip insights from this episode:

Measure DHA in cell membranes to assess dementia risk

Looking at DHA integrated into your cell membranes is a better long-term marker of consumption and its link to dementia risk than simply measuring it in blood plasma.

Critique social media science for deeper understanding

Headlines on social media often bulldoze over a thousand rivulets of context from a scientific study to reach a conclusion as quickly as possible.

Follow the 10-year omega-3 rule to reduce Alzheimer's risk

Based on one analysis, people who consume DHA for a decade or longer have a 64% reduced risk of developing Alzheimer's disease.

Consume omega-3s daily for cognitive protection against dementia

Strong evidence suggests omega-3s, especially DHA, improve cognitive function and protect against dementia when consumed up to one gram per day long-term.

Maintain consistent omega-3 intake to reduce Alzheimer's risk

Omega-3 consumption needs to be consistent, as the protective relationship with Alzheimer's risk is much more certain and potent with long-term exposure.

Aim for one gram of DHA daily to lower dementia risk

Consuming up to one gram of DHA per day for over 10 years is related to a reduced risk of dementia.

DOWNLOAD THE APP

Unlock the wisdom of longevity

DOWNLOAD THE APP

Unlock the wisdom of longevity

DOWNLOAD THE APP

Unlock the wisdom of longevity

Unlock the wisdom of longevity

© Mindsip 2025 – Made with ❤ in Vilnius

Unlock the wisdom of longevity

© Mindsip 2025 – Made with ❤ in Vilnius